Heartflow, Inc. (HTFL) has a MoatMap StockRank of 44/100 based on Quality (41/100), Value (36/100), and Momentum (53/100) factor scores. The current signal is HOLD. Healthcare technology firm with insufficient data and lack of alignment with our active themes, failing our quantitative and qualitative screens.
Heartflow, Inc. provides non-invasive, AI-powered technology to diagnose coronary artery disease (CAD), utilizing standard CT scans to create a 3D model of coronary arteries and simulate blood flow. The company's HeartFlow FFRct Analysis offers clinicians a functional assessment of blockages, reducing the need for invasive procedures and improving diagnostic accuracy. Its proprietary technology and FDA clearance establish a strong competitive position in the cardiovascular diagnostics market.
| Price | $28.93 |
| Market Cap | $2.7B |
| P/E (Forward) | -108.98 |
| Price/Book | 8.68 |
| Return on Equity | -135.3% |
| Return on Invested Capital | -32.1% |
| Debt/Equity | 9.22 |
| Gross Margin | 78.1% |
| Operating Margin | -41.9% |
| Revenue Growth | 41.3% |
| Free Cash Flow | $-49M |
Heartflow, Inc. operates in the Health Information Services industry, part of the Healthcare sector (United States).